STOCKS TELEGRAPH

Tag: XCUR

  • Exicure Inc. (XCUR) Among Gaining Penny Stock Amid Monetary Policy Tightening by the Fed

    Exicure Inc. (XCUR) Among Gaining Penny Stock Amid Monetary Policy Tightening by the Fed

    In the late trading session on Thursday, April 7, 2022, the immune-oncology therapeutics developer, Exicure Inc. (XCUR) witnessed an upsurge. XCUR was among the penny stocks that made some gains as the Fed disclosed a tightening of monetary policy. Thus, the stock surged up by 18.37% in the after-hours to register a value of $0.2474 per share. This upsurge followed an increase of 3.47% in the prior session at $0.2090.

    Source: iStock

    What’s going on?

    On April 6, the Federal Reserve released minutes of its recent meeting which highlighted its plan to reduce the balance sheet by almost $95 billion per month. The monetary policymakers are planning strict measures against the rising inflation in order to curb it. The plan entails a 50 basis point increase in interest rates moving forward.

    This increase in interest rates had been expected for months as inflation continued to peak. But the Russia-Ukraine conflict and prolonged impacts of the pandemic added to this rate increase has everyone worried. On one hand, some are suggesting a possible recession in the near future while others deem it highly unlikely to be the case. But one this is sure Wall Street is up for troubling times ahead.

    Impact on Market and Penny Stocks

    The news initially initiated a sell-off as the stock markets registered red values. However, on the plus side, investors rallied towards penny stocks to make some gains in a situation of market instability. Thus, a rebound was witnessed in the market on Thursday as many penny stocks like XCUR, HMY, and NILE among others traded in the green.

    Penny stocks being priced below the $5 level while having a lesser margin for loss are highly volatile. But seasoned investors with a proper trading plan can secure good profits from single-digit stocks.

    XCUR’s Analysis

    The company faced many challenges in 2021, with the pandemic adding further to its woes. But the tough situation gave way to strategic realignment and refocusing on its business strategy for becoming cash efficient. The company hoped to enter 2022 with a better start but another blow came from many of its leading members resigning. In February certain members of its board as well as the new CEO of just two months submitted their resignations.

    Conclusion

    Despite the company’s relative financial crunch, XCUR is working tirelessly to improve its position. With certain preclinical programs in line for data by the end of the year and others for 2023, the company is actively pursuing partnering opportunities.

  • Exicure Inc. (XCUR) stock Continues on a Bullish Path After hours. Why?

    On March 01, 2022, shares of Exicure Inc. (XCUR) stock continued to rise in the after hours. The company reported no official announcement or SEC filing recently that can be attributed to the uptrend.

    The stock remained bullish with a gain of 4.79% at a volume of 16.58 million shares in regular trading. Investors flocked towards the stock on Tuesday, as the day’s volume was 175% of its 65-day average. XCUR stock traded between $0.1970 and $0.2170 to close the session at a value of $0.2099 per share. Following the close of regular trading, the stock reached $0.2700 in the after-hours, continuing its bullish path. Hence, XCUR stock added a further 28.63% at an active after-hours volume of 8.56 million shares, on Tuesday.

    The Spherical Nucleic Acid-based therapeutic developer, Exicure Inc. was founded in 2011. Currently, its 108.78 million outstanding shares trade at a market capitalization of $21.79 million.

    What is Happening with XCUR?

    Amid the Russian-Ukraine conflict, the stock nosedived to its 52-week low of $0.1360 on February 24 like most. The stock had since been in a mild uptrend. While the new low in the stock was reason enough for the stock rebound, the company also filed an SC 13D/A with the SEC on February 25. While gaining mildly for a number of days, the stock’s bullishness escalated in the after-hours on Tuesday. With no official reason, the stock seems to be gaining on external factors.

    Source: Sutterstock

    In the past five days, XCUR stock has added a good 22.61% while increasing by a mere 3.86% year to date. Moreover, the stock suffered a huge decline of 90.75% in the past year.

    Leadership transition & Board Changes

    On February 04, the company announced certain changes in its leadership and board of directors.

    Resignations

    The company’s then-President and CEO, Brian C. Bock submitted his resignation in order to pursue other opportunities. Upon his resignation, Mr. Bock will serve as a Special Advisor to the CEO during the transition period while remaining in an advisory role to the company.

    Moreover, Timothy P. Walbert, Bosun Hau, and Ander Sassine also tendered their resignations from their positions at XCUR’s board.

    Appointments

    In addition, the company also announced the appointment of certain new members. Dr. Matthias Schroff was appointed as the President and CEO and replaced Mr. Bock on the board.

    Furthermore, Dr. Elizabeth (Betsy) Garofalo was appointed as the Chair of the board and succeeded Mr. Walbert.

  • Exicure Inc. (XCUR) Stock Soars High After Hours. Any Reasons?

    On January 25, Exicure Inc. (XCUR) stock soared in the after-hours to gain a huge 28.24%. The stock seems to be gaining on external factors as there is no official announcement.

    In the regular session, the stock fluctuated between $0.1670 and $0.1501 at 21.25 million shares. XCUR stock closed the session at $0.1629, adding 3.56%. Soon in the after-hours, the stock saw an upsurge as it rose to $0.2089 on Tuesday.

    The Spherical Nucleic Acid-based therapeutics developer, Exicure Inc. has a market capitalization of $17.11 million. Currently, the company has 108.78 million shares outstanding in the market.

    XCUR stock Movement

    After being in a downtrend for the past few days, XCUR stock seems to be in recovery mode right now. The stock touched a low of $0.1420 yesterday, just a little short of its 52-week low of $0.1415. Consequent to this, the stock saw a heavy volume during both the following sessions. In regular trading, the stock traded at 572% of the average volume while it was 11.69 million shares in the after-hours. The recent near low might have something to do with the stock’s comeback along with other external factors. Since, there is no official announcement, SEC filing, or upcoming event in the company’s timeline, external factors seem to be at play here.

    A further study of the stock movement shows a year-to-date loss of 19.40% for XCUR. Moreover, the stock lost a humungous 92.66% last year.

    Recent SEC Filing

    On January 14, the company filed a report with the Securities Exchange Commission. As per the report, XCUR’s board gave a promotion to the company’s Chief Accounting Officer, Elais D. Papadimas. Mr. Papadimas was promoted to the role of Chief Financial Officer, effective January 17, 2022. Moreover, he was also appointed as the company’s corporate secretary.

    In addition, Mr. Papadimas’ promotion resulted in the increase of his annual base salary from $300,000 to $405,000. Also, his target bonus percentage was increased by a further 10% of his annual base salary.

    Furthermore, the increase in the base salary and target bonus percentage was a result of an amendment to his Amended and Restated Employment Agreement. The amendment also makes Mr. Papadimas eligible for a special bonus.

    XCUR’s Financial Overview

    In the third quarter of 2021, the company suffered from a net loss of $23.5 million, against $8.8 million in the year-ago quarter.

    Additionally, XCUR ended the quarter with cash, cash equivalents, short-term investments, and restricted cash of $62.0 million.

  • ‎26 stocks making the biggest moves premarket today

    ‎26 stocks making the biggest moves premarket today

    ‎Mereo BioPharma Group plc (MREO) stock plunged -7.78% to $3.32 in the pre-‎market trading after declaring collaboration and license agreement with Ultragenyx Pharmaceutical ‎Inc. (RARE), for Setrusumab in Osteogenesis Imperfecta.‎

    ‎Naked Brand Group Limited (NASDAQ: NAKD) shares are trading up ‎‎11.45% ‎at ‎‎$0.2044 at the time of writing. Company’s 52-week ranged between $0.07 to $3.70.‎

    ‎Exela Technologies Inc. (XELA) is down more than -9.79% at $0.4128 in pre-market ‎hours Monday December 21, 2020 following the announcement from the firm that it has entered into ‎a 5-year, $145 million term loan facility with Angelo Gordon, a global alternative investment firm. The ‎stock had jumped over 26.10% to $0.46 in the last trading session.‎

    ‎Zomedica Corp. (ZOM) tumbled over -5.22% at $0.1959 in pre-market trading today.‎

    Before the trading started on December 21, 2020, BlackBerry Limited (BB) is down -‎‎3.17% to reach $6.73 after releasing financial results for the three months ended November 30, 2020. It ‎has been trading in a 52-week range of $2.70 to $9.69.‎

    ‎General Electric Company (GE), a Specialty Industrial Machinery company, dropped ‎about -6.11% at $10.15 in pre-market trading Monday after announcing expiration and results of its ‎debt tender offers.‎

    ‎Phunware Inc. (PHUN) lost over -10.38% at $0.95 in pre-‎‎market ‎trading ‎Monday ‎December 21, 2020.‎

    ‎American Airlines Group Inc. (AAL) lost over -7.03% at $15.35 in pre-market trading ‎Monday December 21, 2020.‎

    Before the trading started on December 21, 2020, Carnival Corporation & Plc (CCL) is ‎down -9.79% to reach $19.36. It has been trading in a 52-week range of $7.80 to $51.94.‎

    ‎FuelCell Energy Inc. (FCEL) stock moved down -4.3 percent to $8.9 in the pre-‎market trading after declaring that state regulators have improperly rescinded RFP awards for three ‎fuel cell projects previously selected in the Shared Clean Energy Facility program, putting its state high ‎tech manufacturing job growth at risk.‎

    ‎Exicure Inc. (XCUR) stock soared 7.04% to $2.13 in the pre-‎‎market ‎trading. ‎The ‎most ‎recent rating by BMO Capital Markets, on December 18, 2020, is ‎an ‎Outperform.‎

    ‎Genius Brands International Inc. (GNUS), a Entertainment company, rose about ‎‎3.18% at $1.62 in pre-market trading Monday. The firm recently revealed that it has licensed streaming ‎and select video-on-demand rights to the hit family series, The Wubbulous World of Dr. Seuss (20 x ‎‎22’), from The Jim Henson Company on Kartoon Channel!‎

    ‎SolarWinds Corporation (NYSE: SWI) shares are trading ‎up ‎‎6.7% ‎at ‎‎$15.13 ‎at ‎the ‎time of writing. Company’s 52-week ranged between $11.50 ‎to ‎‎$24.34. ‎Analysts ‎have ‎a ‎consensus ‎price target of $26. ‎

    ‎Norwegian Cruise Line Holdings Ltd. (NCLH) lost over -10.01% at $22.66 in pre-‎market trading Monday December 21, 2020 after reporting that it has closed its previously announced ‎private offering of $850 million aggregate principal amount of its 5.875% senior notes due 2026 (the ‎‎“Notes”).‎

    Before the trading started on December 21, 2020, Nokia Corporation (NOK) is down ‎‎-5.25% to reach $3.79. The company recently declared that it has launched 5G services with Polkomtel, ‎operator of the Plus network, in the capital city of Warsaw as well as other major cities in the eastern ‎part of the country. It has been trading in a 52-week range of $2.34 to $5.14.‎

    ‎Corbus Pharmaceuticals Holdings Inc. (CRBP) is up more than 12.0% at $1.68 in pre-‎‎‎‎‎‎‎‎market hours Monday December 21, 2020. The stock had jumped ‎over ‎‎11.11% ‎to ‎‎$1.50 ‎in ‎the ‎last ‎trading session.‎

    ‎Schlumberger Limited (NYSE: SLB) shares are trading down -6.95% at $20.76 at the ‎time of writing. The firm will hold a conference call on January 22, 2021 to discuss the results for the ‎fourth quarter and full year ending December 31, 2020. Company’s 52-week ranged between $11.87 to ‎‎$41.14.‎

    ‎Exxon Mobil Corporation (NYSE: XOM) shares are trading down -5.27% ‎at ‎‎$40.48 ‎at ‎the time of writing. Company’s 52-week ranged between $30.11 to $71.37. Analysts ‎have ‎a ‎consensus ‎price target of $52.‎

    ‎Transocean Ltd. (RIG) is down more than -14.92% at $2.11 in pre-market hours ‎Monday December 21, 2020 after announcing successful court ruling granting its motion for summary ‎judgment and holding internal reorganization did not violate indenture. The stock had dropped over -‎‎3.50% to $2.48 in the last trading session.‎

    ‎Simon Property Group Inc. (SPG) tumbled over -5.07% at $81.1 in pre-market ‎trading today. The firm recently declared a common stock dividend for the fourth quarter 2020.‎
    ‎
    ‎Energy Transfer LP (ET), a Oil & Gas Midstream company, dropped about -‎‎‎‎5.9% ‎at ‎‎$6.38 in pre-market trading Monday.‎

    ‎Cinedigm Corp. (CIDM) stock moved up 4.11 percent to $0.798 in the pre-market ‎trading after revealing the launch of The Bob Ross Channel on the Roku platform.‎

    Before the trading started on December 21, 2020, Coty Inc. (COTY) is down -6.15% ‎to reach $6.56. The company lately reported two additions to its Board of Directors with the ‎appointments of Anna Adeola Makanju and Mariasun Aramburuzabala Larregui. It has been trading in ‎a 52-week range of $2.65 to $13.01.‎

    ‎JPMorgan Chase & Co. (JPM) gained over 2.24% at $121.75 in pre-‎‎‎‎market ‎trading ‎Monday December 21, 2020. ‎

    ‎Apache Corporation (NASDAQ: APA) shares are trading down -11.29% at $13.6 at ‎the time of writing after announcing the donation of more than 64,000 trees to 56 nonprofit partner ‎organizations through the annual Apache Tree Grant Program. Company’s 52-week ranged between ‎‎$3.80 to $33.77. Analysts have a consensus price target of $16.‎